Concord Drugs has announced that its upcoming annual general meeting will take place via video conferencing, alongside temporary closures of the register of members and share transfer books for scheduling purposes.

Shareholders are provided electronic voting access through a designated depository platform to cast votes ahead of the meeting.

These administrative updates ensure smooth corporate governance and shareholder participation while maintaining standard operational compliance.